T-Cure Biosciences
Dr. Dubinett is Professor of Medicine, Pathology and Laboratory Medicine, Vice-Chancellor of Translational Research at UCLA. He is Chief of the Division of Pulmonary and Critical Care Medicine and Director of the Jonsson Comprehensive Cancer Center’s Lung Cancer Research Program. As a member of NCI’s Translational Research Working Group, Dr. Dubinett participates in designing pathways to clinical goals and has been the principal investigator on numerous NCI and private industry-sponsored cancer immunotherapy clinical trials. He previously chaired the FDA Cellular, Tissue, and Gene Therapies Advisory Committee to oversee cellular and immunotherapy studies for cancer. Dr. Dubinett received his MD from New Jersey Medical School, completed his residency and fellowship training at Harvard Medical School and Massachusetts General Hospital.
This person is not in the org chart
This person is not in any offices
T-Cure Biosciences
Founded by early pioneers of T cell receptor (TCR) therapy, T-Cure strives to find the cure for human cancer using its cutting-edge TCR-T technologies. Using its proprietary iSORT TCR discovery platform, T-Cure expects to rapidly grow its pipeline of therapy candidates. The Company believes its TCR holds great promise in treating patients unaddressed by current modalities.